MedTrace Logo

Graded TTCE for Post-Embolization PAVM Monitoring

NCT02936349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2019-11-08

No results posted yet for this study

Summary

Current HHT guidelines recommend CT scan to detect new or recurrent PAVMs after embolotherapy. Recent studies using transthoracic contrast echocardiography (TTCE) shunt grade for PAVM screening suggest that graded TTCE can accurately predict the size of PAVMs on chest CT and their amenability to embolization. This study's purpose is to evaluate whether TTCE shunt grade can also accurately predict PAVM size and amenability to treatment in patients who are post-embolization.

Conditions

  • Hereditary Hemorrhagic Telangiectasia (HHT)

Interventions

OTHER

Transthoracic Contrast Echocardiogram

A transthoracic contrast echocardiogram (TTCE) is a still or moving image of the internal parts of the heart using ultrasound following the injection of microbubble contrast (agitated saline) into a vein in the arm, which then travels to the heart.

Sponsors & Collaborators

Principal Investigators

  • Scott O Trerotola, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02936349 on ClinicalTrials.gov